NEWS
NORMAN, OKLA. – Wei R. Chen, Ph.D., Stephenson Chair, Professor and Interim Director of the Stephenson School of Biomedical Engineering, recently organized a session titled Immunophotonics for the Gordon Research Conference Optics and Photonics in Medicine and Biology, held from July 7 to 12, in Lewiston, Maine. Chen also gave an oral presentation, "Localized Immunophotonics for the Treatment of Metastatic Cancers" at the conference.
Chen presented recent results of pre-clinical and clinical results in cancer treatment using their novel immunophotonics technology. Chen’s doctoral students, Trisha Valerio and Coline Furrer, also presented their research results at the conference with posters.
Chen is a pioneer in the field of immunophotonics. His research team is among the first to use biophotonics to induce immune responses to treat late stage, metastatic cancers through the abscopal effect — a phenomenon when a local therapy shrinks not only the targeted tumor, but other untargeted tumors in the body. Specifically, Chen’s team developed a unique combination of laser ablation and a novel immunological drug for the treatment of late-stage, metastatic cancers through local intervention.
Chen is a co-founder of Immunophotonics, Inc. and has served as a member of its Board of Directors since its inception. Immunophotonics has been conducting clinical trials in Europe for the past several years. In 2023, the US Food and Drug Administration approved a phase 1b/2a multiple center clinical trial for late-stage patients with colorectal cancer, non-small cell lung cancer, and soft tissue sarcoma, using the novel therapy developed by Chen’s team.
About the University of Oklahoma
Founded in 1890, the University of Oklahoma is a public research university located in Norman, Oklahoma. As the state’s flagship university, OU serves the educational, cultural, economic and health care needs of the state, region and nation. OU was named the state’s highest-ranking university in U.S. News & World Report’s most recent Best Colleges list. For more information about the university, visit ou.edu.
The Hudson Fellows in Public Health Program – a select group of doctoral students at the University of Oklahoma Hudson College of Public Health – will observe its 10th anniversary on April 9 with the annual Hudson Fellows Symposium. The event will feature a noontime lecture by health innovation leader Vivian S. Lee, M.D., Ph.D., MBA.
New research from University of Oklahoma researchers, published in Cell Reports, reveals that a hormone that reverses obesity in mice appears to work by signaling to a brain region involved in metabolism and appetite regulation, the same area targeted by the popular GLP-1 drugs.
The University of Oklahoma’s Max Westheimer Airport has received the prestigious Airport of the Year Award for 2026 from the Oklahoma Airport Operators Association. Airport Director Lance Lamkin was also named the 2026 Airport Manager of the Year.
